Literature DB >> 233700

Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.

E A Werder, J A Fischer, R Illig, H P Kind, S Bernasconi, A Fanconi, A Prader.   

Abstract

Forty patients with hypocalcemia and/or Albright's hereditary osteodystrophy were studied. Based on the estimation of serum calcium and parathyroid hormone (PTH) levels as well as the urinary cAMP response to infusions with parathyroid extract, it was possible to classify all of the patients studied as cases with idiopathic hypoparathyroidism (n = 6, low PTH, normal cAMP response), pseudohypoparathyroidism (PHP) type I (n = 18, high PTH, low cAMP response) and type II (n = 2, high PTH, normal cAMP response), as well as pseudopseudohypoparathyroidism (n = 14, normal PTH, normal cAMP response). In three cases studied at the age of 12, 17, and 23 yr, the signs of Albright's hereditary osteodystrophy were not observed. PTH levels were unusually high for a given serum calcium concentration in some patients with PHP, the increased PTH levels were, however, normalized during iv calcium infusions. In two young children with PHP, a gradual increase of serum PTH levels occurred despite persistent normocalcemia over a period of 3 yr. This suggests that factors other than hypocalcemia or frequent small unobservable falls of the serum calcium concentration, such as a deficient formation of 1,25-dihydroxyvitamin D3, secretion of an abnormal PTH, or an abnormal metabolism of the hormone, may contribute to the secondary hyperparathyroidism in PHP.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233700     DOI: 10.1210/jcem-46-6-872

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Diagnosis and treatment of primary hyperparathyroidism.

Authors:  M A Dambacher; U Binswanger; J A Fischer
Journal:  Urol Res       Date:  1979-09

2.  A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

3.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

Review 4.  Imprinting in Albright's hereditary osteodystrophy.

Authors:  S J Davies; H E Hughes
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

5.  Familial pseudohypoparathyroidism without somatic anomalies.

Authors:  J S Winter; I A Hughes
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

6.  Differential diagnosis of hypoparathyroid disorders during childhood.

Authors:  M Ishida; Y Seino; T Simotsuji; T Ishii; K Yamaoka; T Harada; H yabuuchi; K Nishimura
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

7.  Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.

Authors:  Y Seino; M Ishida; K Yamaoka; T Shimotsuji; T Ishii; H Yabuuchi; M Fukase; T Fujita
Journal:  Eur J Pediatr       Date:  1981-02       Impact factor: 3.183

8.  A novel mutation causing pseudohypoparathyroidism 1A with congenital hypothyroidism and osteoma cutis.

Authors:  Tamar Lubell; Maria Garzon; Kwame Anyane Yeboa; Bina Shah
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.